Join us for an insightful discussion on the transformative potential of psychedelic therapy, focusing on studies on psilocybin, practitioner access, and ethical considerations. We will explore the integration of psychedelic therapies in clinical practice across different states and envision the future of licensed practice in Minnesota. Topics include trauma healing for marginalized communities, the role of EEG data and neurofeedback, safe use versus harm reduction, and the challenges of navigating state and federal laws. We will also highlight advocacy, training programs, and the potential of psychedelics to reimagine and enhance Western medical models, particularly for those underserved by traditional treatments.